Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,627 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Humanized Biomimetic Nanovesicles for Neuron Targeting.
Zinger A, Cvetkovic C, Sushnitha M, Naoi T, Baudo G, Anderson M, Shetty A, Basu N, Covello J, Tasciotti E, Amit M, Xie T, Taraballi F, Krencik R. Zinger A, et al. Among authors: xie t. Adv Sci (Weinh). 2021 Oct;8(19):e2101437. doi: 10.1002/advs.202101437. Epub 2021 Aug 11. Adv Sci (Weinh). 2021. PMID: 34382379 Free PMC article.
β-Adrenergic signaling in skin cancer.
Batalla-Covello J, Ali S, Xie T, Amit M. Batalla-Covello J, et al. Among authors: xie t. FASEB Bioadv. 2022 Jan 6;4(4):225-234. doi: 10.1096/fba.2021-00097. eCollection 2022 Apr. FASEB Bioadv. 2022. PMID: 35415461 Free PMC article. Review.
Schwann Cells Induce Phenotypic Changes in Oral Cancer Cells.
Santi MD, Zhang M, Salvo E, Asam K, Viet CT, Xie T, Amit M, Aouizerat B, Ye Y. Santi MD, et al. Among authors: xie t. Adv Biol (Weinh). 2022 Sep;6(9):e2200187. doi: 10.1002/adbi.202200187. Epub 2022 Aug 4. Adv Biol (Weinh). 2022. PMID: 35925609 Free PMC article.
Targeting the Nerve-Cancer Circuit.
Ye Y, Xie T, Amit M. Ye Y, et al. Among authors: xie t. Cancer Res. 2023 Aug 1;83(15):2445-2447. doi: 10.1158/0008-5472.CAN-23-1754. Cancer Res. 2023. PMID: 37470842
Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade.
Baruch EN, Nagarajan P, Gleber-Netto FO, Rao X, Xie T, Akhter S, Adewale A, Shajedul I, Mattson BJ, Ferrarotto R, Wong MK, Davies MA, Jindal S, Basu S, Harwood C, Leigh I, Ajami N, Futreal A, Castillo M, Gunaratne P, Goepfert RP, Khushalani N, Wang J, Watowich S, Calin GA, Migden MR, Vermeer P, D'Silva N, Yaniv D, Burks JK, Gomez J, Dougherty PM, Tsai KY, Allison JP, Sharma P, Wargo J, Myers JN, Gross ND, Amit M. Baruch EN, et al. Among authors: xie t. Res Sq [Preprint]. 2023 Jul 18:rs.3.rs-3161761. doi: 10.21203/rs.3.rs-3161761/v1. Res Sq. 2023. PMID: 37503252 Free PMC article. Preprint.
Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance.
Santi MD, Zhang M, Liu N, Viet CT, Xie T, Jensen DD, Amit M, Pan H, Ye Y. Santi MD, et al. Among authors: xie t. Pharmaceuticals (Basel). 2023 Nov 3;16(11):1558. doi: 10.3390/ph16111558. Pharmaceuticals (Basel). 2023. PMID: 38004424 Free PMC article. Review.
3,627 results